Table 1.
Females | Males | |||||
---|---|---|---|---|---|---|
Igfbp4+/+ | Igfbp4−/− | t-Test | Igfbp4+/+ | Igfbp4−/− | t-Test | |
MS/BS (%) | 38.7 ± 1.77 | 36.21 ± 1.31 | 0.076 | 41.16 ± 2.74 | 28.46 ± 3.59 | 0.049 |
MAR (µm/day) | 1.82 ± 0.02 | 1.63 ± 0.07 | 0.037 | 1.04 ± 0.06 | 0.93 ± 0.04 | 0.215 |
BFR (µm3/µm2/day) | 0.68 ± 0.06 | 0.59 ± 0.04 | 0.216 | 0.41 ± 0.04 | 0.30 ± 0.03 | 0.062 |
Ob.S/B.Pm | 12.77 ± 1.21 | 16.10 ± 2.10 | 0.207 | 2.96 ± 0.81 | 1.68 ± 0.35 | 0.139 |
N.Ob/B.Pm | 8.72 ± 0.83 | 10.92 ± 1.31 | 0.173 | 2.24 ± 0.64 | 1.66 ± 0.31 | 0.405 |
OS/BS µ | 9.21 ± 1.38 | 7.81 ± 1.42 | 0.485 | 11.03 ± 1.31 | 4.28 ± 1.09 | 0.003 |
O.Th | 2.58 ± 0.12 | 2.59 ± 0.12 | 0.158 | 2.36 ± 0.19 | 2.11 ± 0.13 | 0.308 |
Oc.S/BS | 12.3 ± 0.79 | 14.97 ± 0.60 | 0.022 | 6.99 ± 0.46 | 6.69 ± 0.92 | 0.782 |
N.Oc/B.Pm | 4.24 ± 0.18 | 5.05 ± 0.21 | 0.016 | 2.95 ± 0.17 | 2.77 ± 0.31 | 0.624 |
ES/BS | 3.96 ± 0.35 | 6.38 ± 0.99 | 0.048 | 1.23 ± 0.37 | 1.90 ± 0.45 | 0.282 |
N.Ad/T.Ar | 42.73 ± 8.16 | 50.12 ± 4.19 | 0.482 | 5.13 ± 2.29 | 5.79 ± 2.94 | 0864 |
Static and dynamic histomorphometry analysis of proximal tibia labeled with calcein and demeclocycline from Igfbp4−/− mice compared to littermate controls at 16 weeks of age. Bold values represent measurements for which the difference from littermate gender-matched controls reach statistical significance.
BFR/BS, bone formation rate/bone surface; ES/BS, erosion surface/bone surface; MAR, mineral aposition rate; MS/BS, mineralized surface/bone surface; N.Ad/T.Ar, number of adipocyte/total area; N.Ob/B.Pm, number of osteoblast/bone perimeter; N.Oc/B.Pm, number of osteoclast/bone perimeter; Ob.S/B.Pm, osteoblast surface/bone perimeter; Oc.S/BS, osteoclast surface/bone surface; OS/BS, osteoid surface/bone surface; O.Th, osteoid thickness. (n = 5–6/genotype/gender, t-test P values were considered statistically different when P value <0.05.)